Sigma SML1791 Urolithin A Drop-In Replacement For Mitophagy
HPLC Purity Grades & COA Parameters: Eliminating Residual Ellagic Acid to Prevent Peak Tailing in Competitor Batches
When sourcing a drop-in replacement for Sigma SML1791, procurement and R&D teams must look beyond headline purity percentages to the specific impurity profile that impacts assay integrity. Urolithin A is synthesized or isolated as an ellagic acid metabolite, and the efficiency of the final purification step dictates the presence of residual precursor. In our engineering experience, trace levels of ellagic acid can cause significant peak tailing in reverse-phase HPLC methods commonly used to quantify Uro-A in cell lysates. This tailing distorts integration windows and compromises the accuracy of mitophagy flux measurements. Our manufacturing process for 3,8-Dihydroxyurolithin employs a targeted crystallization protocol that minimizes residual ellagic acid to levels that maintain chromatographic symmetry identical to the SML1791 benchmark. This ensures that your analytical methods require no re-validation when switching suppliers. For a direct comparison of technical parameters, refer to the table below. Note that specific numerical limits are batch-dependent and must be verified against the batch-specific COA provided with each shipment.
| Parameter | Ningbo Inno Pharmchem Specification | Sigma SML1791 Equivalent Benchmark |
|---|---|---|
| HPLC Purity | ≥98% (Batch COA) | ≥98% |
| Residual Ellagic Acid | <0.5% (Batch COA) | <0.5% |
| Appearance | White to Off-White Crystalline Powder | White to Off-White Crystalline Powder |
| Loss on Drying | ≤1.0% (Batch COA) | ≤1.0% |
Our product serves as a reliable performance benchmark for cost-efficiency without compromising the analytical rigor required for high-value mitophagy research. By eliminating residual ellagic acid, we prevent the chromatographic artifacts that often necessitate method adjustments in competitor batches.
DMSO Stock Preparation & Solvent Compatibility: Technical Specs for Stable Urolithin A Working Solutions
Proper stock preparation is critical for maintaining the stability and solubility of Urolithin A in biological assays. While often categorized broadly as an anti-aging compound in literature, the technical focus for R&D is the precise handling of this molecule to avoid precipitation artifacts. Urolithin A exhibits high solubility in anhydrous DMSO but demonstrates a sharp solubility cliff when diluted into aqueous buffers such as PBS or cell culture media. Field data indicates that the solubility threshold drops significantly below 100 µM in aqueous environments without surfactants. We recommend preparing 100 mM stock solutions in DMSO and storing them at -20°C to minimize hydrolysis. However, a non-standard parameter often overlooked is the impact of thermal cycling on DMSO stocks. Repeated freeze-thaw cycles can induce micro-crystallization that is invisible to the naked eye but leads to inconsistent dosing and pipette clogging during serial dilution. To mitigate this, aliquot DMSO stocks immediately upon preparation and avoid unnecessary thawing. For detailed solubility data and bulk availability, review our Urolithin A technical specifications.
Crystalline Polymorph Consistency & Batch-to-Batch Reproducibility: Standardizing Urolithin A Matrix for Reliable Assay Readouts
Batch-to-batch reproducibility in mitophagy assays relies heavily on the consistency of the crystalline polymorph. Variations in crystal lattice energy can alter dissolution kinetics, leading to inconsistent effective concentrations in cell culture even when the nominal mass is identical. Our manufacturing process maintains a consistent polymorphic form for Urolithin A, ensuring that the dissolution rate matches the kinetic profile expected from the SML1791 reference standard. This eliminates variability in EC50 determinations across different production lots. We utilize Differential Scanning Calorimetry (DSC) to monitor polymorphic consistency, tracking the endothermic melting peak temperature and enthalpy. Consistent DSC profiles confirm that the physical state of the material remains uniform, which is essential for high-throughput screening where minor variations in dissolution can skew dose-response curves. This engineering control ensures that your assay readouts reflect biological activity rather than material variability.
Trace Impurity Profiling & Fluorescence Interference: How Sub-Threshold Contaminants Skew High-Throughput Screening Data
In high-throughput screening for mitophagy, autofluorescence from trace impurities can generate false positives or mask subtle biological signals. While standard Certificates of Analysis list total impurities, the spectral profile of these impurities is equally important. Our trace impurity profiling ensures that sub-threshold contaminants do not exhibit fluorescence in the 488/520 nm range commonly used for mitochondrial staining and LC3-II detection. This is critical when using Uro-A as a positive control, as background noise from impurities can interfere with the quantification of mitochondrial membrane potential or autophagosome formation. By rigorously controlling the impurity profile, we ensure that the signal-to-noise ratio in your assays remains optimal. This level of quality control is particularly important for researchers developing novel derivatives or conducting sensitive flow cytometry analyses where background fluorescence can compromise data integrity.
Exact Filtration Protocols & Bulk Packaging Specifications: Preventing Microplate Reader Clogging and Optimizing Procurement Logistics
Microplate reader clogging is a common failure mode in automated assays using Urolithin A, often caused by undissolved particles or micro-crystals. We recommend a two-stage filtration protocol: initial dissolution in DMSO followed by 0.45 µm filtration, then final dilution filtration at 0.22 µm using PTFE filters compatible with organic solvents. This protocol ensures particle-free working solutions that protect automated liquid handling systems. Regarding logistics, Ningbo Inno Pharmchem ships Urolithin A in sealed amber glass bottles or multi-layer aluminum foil bags within corrugated cartons to protect against light and moisture degradation. For larger procurement volumes, we utilize IBC containers with nitrogen blanketing to maintain stability during transit and storage. Shipping methods are calculated based on weight and destination, focusing on secure physical transit and timely delivery to support your supply chain reliability. All packaging is designed to preserve the chemical integrity of the product without compromising handling efficiency.
Frequently Asked Questions
How can we verify the polymorphic form of Urolithin A batches to ensure assay reproducibility?
Polymorphic verification is conducted using Differential Scanning Calorimetry (DSC). Our technical team provides DSC thermograms with the COA, showing distinct endothermic melting peaks. Consistent peak temperature and enthalpy values across batches confirm a single polymorphic form, which is essential for maintaining uniform dissolution kinetics in mitophagy assays. Please request the DSC report from our support team for batch-specific verification.
What are the acceptable residual solvent limits for Urolithin A intended for in vitro cell culture applications?
Residual solvent limits must comply with ICH Q3C guidelines for pharmaceutical substances. For cell culture applications, residual DMSO and other solvents should be minimized to prevent cytotoxicity. Our manufacturing process ensures residual solvents are well below ICH thresholds. However, the exact residual solvent profile varies by batch. Please refer to the batch-specific COA for detailed GC-MS residual solvent analysis to confirm suitability for your specific cell line sensitivity.
What steps should be taken to resolve DMSO precipitation when diluting Urolithin A stocks for high-throughput screening?
DMSO precipitation during dilution often results from exceeding the solubility limit in the aqueous buffer or temperature fluctuations. To resolve this, prepare a concentrated stock solution in anhydrous DMSO and store at -